News | May 16, 2025
Remedium Lifecare secures Rs. 182.7 crore export deal
The CDMO upgrade represents a transformational step for Remedium Lifecare
The CDMO upgrade represents a transformational step for Remedium Lifecare
Standalone profit from operations for the quarter were Rs. 162 crores
EBITDA before special items decreases to €4.08 billion (7.4%)
Express Scripts has added YESINTEK to the National Preferred Formulary (NPF) effective March 21, 2025
These observations are procedural in nature and none of them are related to data integrity
Investment demonstrates confidence in America’s commitment to science and innovation
The inspection concluded with 6 observations and none of them were related to Data Integrity
Syngene reported revenue growth of 11% year-on-year, and 8% sequentially crossing the Rs. 1,000 Cr in a quarter threshold for the first time
The company delivered revenues of Rs. 5,554 crore, representing 10% growth in FY25
The transaction is expected to be completed by May 15, 2025 or such other date as may be mutually agreed
Subscribe To Our Newsletter & Stay Updated
